☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Genetic Diseases
Entos Entered into an Agreement with BioMarin for Gene Therapies to Treat Genetic Diseases
November 16, 2021
Moderna Entered into a Research and Development Collaboration with Metagenomi to Develop In Vivo Gene Editing Therapeutics
November 2, 2021
Vertex Collaborates with Mammoth Biosciences to Develop In Vivo Gene-Editing Therapies for Genetic Diseases
October 27, 2021
Roche to Acquire Spark Therapeutics for $4.3B
February 25, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
